Roche CEO Severin Schwan (Image: AP)
Roche — surprise — delays $4.3B Spark buyout again as regulators hover
Roche has yet again delayed their Spark buyout.
The Swiss giant extended the window on the $4.3 billion gene therapy acquisition through November 25th. It …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
